Benzinga | Jul 31, 2020 06:34AM EDT

Immunogen Q2 EPS $(0.14) Beats $(0.17) Estimate, Sales $15.03M Beat $14.59M Estimate

Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.17) by 17.65 percent. This is a 51.72 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $15.03 million which beat the analyst consensus estimate of $14.59 million by 2.98 percent. This is a 3.33 percent decrease over sales of $15.54 million the same period last year.